Systematic Review of Treatment Effectiveness and Outcome Measures for Enthesitis in Psoriatic Arthritis

被引：45

作者：

Orbai, Ana-Maria ^{[1
]}

Weitz, Joshua ^{[2
]}

Siegel, Evan L. ^{[3
]}

Siebert, Stefan ^{[4
]}

Savage, Laura J. ^{[5
]}

Aydin, Sibel Z. ^{[6
]}

Luime, Jolanda J. ^{[7
]}

Elkayam, Ori ^{[8
,9
]}

Neerinckx, Barbara ^{[10
]}

Urbancek, Slavo ^{[11
]}

de Vlam, Kurt ^{[10
]}

Ritchlin, Christopher T. ^{[12
]}

机构：

[1] Johns Hopkins Arthrit Ctr, Baltimore, MD 21224 USA

[2] Dermatol Associates Rochester, Rochester, MN USA

[3] Arthrit & Rheumatism Associates, Rockville, MD USA

[4] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland

[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England

[6] Koc Univ, Fac Med, Dept Rheumatol, Istanbul, Turkey

[7] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands

[8] Tel Aviv Univ, Tel Aviv Med Ctr, Dept Rheumatol, IL-69978 Tel Aviv, Israel

[9] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel

[10] Univ Hosp Leuven, Leuven, Belgium

[11] FD Roosevelt Hosp, Dept Dermatol, Banska Bystrica, Slovakia

[12] Univ Rochester, Med Ctr, Div Rheumatol Allergy & Immunol, Rochester, NY 14642 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 11期

关键词：

ENTHESITIS; ENTHESOPATHY; PSORIATIC ARTHRITIS; OUTCOME MEASURES; TREATMENT; DOUBLE-BLIND; ANKYLOSING-SPONDYLITIS; MONOCLONAL-ANTIBODY; CONTROLLED TRIAL; PLACEBO; EFFICACY; PHASE-3; SAFETY; USTEKINUMAB; SPONDYLOARTHRITIS;

D O I：

10.3899/jrheum.140878

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Enthesitis is a characteristic feature of psoriatic arthritis (PsA) and is important in disease pathogenesis and classification. Use of clinical outcome measures for enthesitis is heterogeneous, and only 1 measure has been specifically developed and validated in PsA. Ultrasound and magnetic resonance imaging assessments of enthesitis may have advantages over clinical examination but are insufficiently studied. As part of an update of treatment recommendations by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), we performed a systematic literature review and identified randomized controlled trials with enthesitis outcomes in PsA. For each treatment agent we calculated treatment effect sizes (where applicable) and graded the level of evidence.

引用

页码：2290 / 2294

页数：5

共 28 条

[1] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C
Krueger, GG
de Vlam, K
Birbara, C
Beutler, A
Guzzo, C
Zhou, B
Dooley, LT
Kavanaugh, A
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1150 - 1157
[2] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
Antoni, CE
Kavanagh, A
Kirkham, B
Tutuncu, Z
Burmester, GR
Schneider, U
Furst, DE
Molitor, J
Keystone, E
Gladman, D
Manger, B
Wassenberg, S
Weier, R
Wallace, DJ
Weisman, MH
Kalden, JR
Smolen, J
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1227 - 1236
[3] The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development
Aydin, Sibel Z.
Ash, Zoe R.
Tinazzi, Ilaria
Castillo-Gallego, Concepcion
Kwok, Chung
Wilson, Caroline
Goodfield, Mark
Gisondi, Paolo
Tan, Ai Lyn
Marzo-Ortega, Helena
Emery, Paul
Wakefield, Richard J.
McGonagle, Dennis G.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : 992 - 995
[4] Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study
Clegg, DO
Reda, DJ
Mejias, E
Cannon, GW
Weisman, MH
Taylor, T
BudimanMak, E
Blackburn, WD
Vasey, FB
Mahowald, ML
Cush, JJ
Schumacher, HR
Silverman, SL
Alepa, FP
Luggen, ME
Cohen, MR
Makkena, R
Haakenson, CM
Ward, RH
Manaster, BJ
Anderson, RJ
Ward, JR
Henderson, WG
[J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (12): : 2013 - 2020
[5] Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis - A Department of Veterans Affairs cooperative study
Clegg, DO
Reda, DJ
Weisman, MH
Blackburn, WD
Cush, JJ
Cannon, GW
Mahowald, ML
Schumacher, HR
Taylor, T
BudimanMak, E
Cohen, MR
Vasey, FB
Luggen, ME
Mejias, E
Silverman, SL
Makkena, R
Alepa, FP
Buxbaum, J
Haakenson, CM
Ward, RH
Manaster, BJ
Anderson, RJ
Ward, JR
Henderson, WG
[J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (12): : 2004 - 2012
[6] GRAPPA Treatment Recommendations: An Update from the GRAPPA 2013 Annual Meeting
Coates, Laura C.
Ritchlin, Christopher T.
Kavanaugh, Arthur F.
[J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1237 - 1239
[7] A POWER PRIMER
COHEN, J
[J]. PSYCHOLOGICAL BULLETIN, 1992, 112 (01) : 155 - 159
[8] Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
[9] The risks and benefits of glucocorticoid treatment for tendinopathy: A systematic review of the effects of local glucocorticoid on tendon
Dean, Benjamin John Floyd
Lostis, Emilie
Oakley, Thomas
Rombach, Ines
Morrey, Mark E.
Carr, Andrew J.
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 43 (04) : 570 - 576
[10] Genovese MC, 2007, J RHEUMATOL, V34, P1040

← 1 2 3 →